Summary
CLEMAX is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €2.7m and a net result of €646,456. Equity remains stable across the filed financial years (±1.3% per year). Its solvency ranks better than 77% of 3,018 sector peers (NACE 66, financial year 2025). The company has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-06
NBB filing
Annual accounts filed
financial year 2025 · micro format
28-05
Gazette deed
General meeting · Director reappointment
Director resignation
2025
31-12
Financial
Highest result from 2018 to 2025net €646,456 ▲41.1%
Operating result €936,342, net result €646,456, both a record.
24-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
04-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
12-07
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
04-07
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
31-12
Financial
Liquidity triplescurrent ratio 1.76
Current ratio from 0.59 to 1.76; short-term debt falls from €700,934 to €324,289.
22-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
01-07
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
14-06
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
25-06
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
2017
05-07
NBB filing
Annual accounts filed
financial year 2016 · micro format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 17 annual accounts filed, the latest 10 are here; all are under Financials.
0 of 6 deeds read
About the unread acts
We know of 6 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.